Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Genix Pharmaceuticals Corporation (V:GENX)

Business Focus: Special Foods & Welbeing Products

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for GENX within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jul 15, 2021 08:47 ET
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") Genix is pleased to announce that, pursuant to a Health Canada Drug Establishment License (DEL) inspection, carried out at its warehouse premises on June 22, 2021, the Company has now received a Notice of Compliant Rated Inspection with a compliant (C) rating. This rating means that at the time of the inspection, its activities were fully in compliance with the Food and Drugs Act and its associated regulations and that the Company's DEL has been approved.
Read full article
Jun 21, 2021 08:30 ET
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company) is pleased to announce that it has received approval to begin trading its common shares on the OTC Markets Group's OTCQB Venture Market in the United States under the symbol "GENPF". The Company's common shares will begin trading on the OTCQB Marketplace today, June 21st, 2021 and will continue to trade on the TSX Venture Exchange under the symbol "GENX".
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-0.64
--
--
Price to Sales - TTM
--
22.99
11.70
Price to Book - most recent quarter
2.15
3.01
3.00
Price to Cash Flow per share - TTM
--
26.71
13.22
Price to Free Cash Flow per share - TTM
--
--
19.84
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 20213,0002,821
Aug 31, 2021179-537
Aug 15, 20217160
See Short Report

Business Summary

Sector:  Consumer Non-Cyclicals Industry:  Food Processing

Genix Pharmaceuticals Corporation, formerly Alta Natural Herbs & Supplements Ltd, is a dietary supplements and neutraceuticals company. It manufactures and converts dietary supplements and neutraceuticals (herbal, botanical and marine-based) for the natural healthcare products industry. It develops and manufactures a range of dietary supplements and neutraceuticals for the supplement industry. It is a contract manufacturer/converter of raw material powders, with all conversion, from powders to capsules to bottling and packaging. Its raw material powders are encapsulated in hard gelatin or vegetarian capsules. It engages in the contract manufacturing of dietary supplements for a range of customers ranging from naturopathic practitioners to chains. It operates a Cafe, which serves health meals, drinks, function foods and supplies nutrition supplements. It produces and distributes various dietary supplements into Hong Kong, South Korea, Germany and Italy.

See business summary

 

Twitter

Search (past week) for $GENX.CA GENX.V

  • No tweets found